Redwood Shores, Calif.—Just as computerizing medical files for the general public is seen as a means of controlling healthcare costs, doing so more efficiently for the huge data sets that are compiled during clinical trials has become a critical need to speed the process and produce research results at lower cost. DreamCIS, a leading contract research organization in Korea, is the most recent collaborator to select Oracle Health Sciences applications to help increase efficiency in clinical trials data collection and improve data quality.
DreamCIS will use Oracle Clinical and Oracle Remote Data Capture (RDC) 4.5.3 to help meet global standards for clinical trials data management and achieve higher quality local clinical trial services.
"DreamCIS is one of the leading CROs in Korea," says Yashi Kant, Oracle's Asia Pacific vice president. "Its goal to become one of the top CROs in Asia was a driving force behind the decision to form a strategic relationship with us. DreamCIS wanted to align its strategy around—and improve its systems—using Oracle's proven, best-in-class applications. The organization required a robust, reliable and scalable clinical data management system to replace its legacy clinical software, and help the company's data management and biometrics center to become an Asian clinical trial data management hub. DreamCIS really saw the value in the Oracle Health Sciences applications during the evaluation and selection process, and we look forward to working with them and supporting their strategy."
Oracle Health Sciences provides the life sciences sector with fully integrated clinical data management and electronic data capture (EDC) applications, while also providing "best-in-class functionality," Kant says. Oracle Clinical and Oracle Remote Data Capture (RDC) are integrated solutions that can be easily deployed using a single study definition. Oracle RDC 4.5.3, the latest release, is also completely Web-based, with a "zero client footprint" for the HTML data entry window. This enables improved global access and performance for life sciences organizations to conduct global clinical studies more cost effectively, whether using traditional pen and paper, electronic data capture or hybrid methods. Oracle Clinical and Oracle Remote Data Capture have been widely adopted by global health science organizations, including CROs, pharmaceutical and biotechnology companies. DreamCIS is the first CRO in Korea to adopt the applications.
"Oracle Health Sciences applications are not only equipped with outstanding technology but also offer superior system reliability, compatibility and compliance," says Hee-Joong Koh, director of DreamCIS' Biometrics Center. "Oracle's proven experience in the health sciences sector was important to us, and we believe their solutions will enable us to raise our data management levels to global standards and help us become the leader in the Asian clinical trial markets in the future."
In a June 2009 report, IDC Health Insights, an advisory services and market research firm focused on the healthcare and life science markets, ranked Oracle as the top vendor for enterprise life sciences software applications. The report cites Oracle's increased commitment and focus on life sciences for driving its leading share of the $2.95 billion that IDC Health Insights estimates is spent annually on software in the life sciences sector. According to the report, "Oracle easily topped the chart, with nearly $60 million more than the second-place SAP." The ranking is based solely on software license revenue derived from life sciences customers, and the study examined only enterprise solutions, which included: business intelligence/analytics, clinical software, customer relationship management, content management, revenue management/enterprise resource planning, human resources, manufacturing, supply chain management, product lifecycle management, research and development (R&D) informatics and R&D discovery platforms.
